Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page’s displayed site/version label has been updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor update to the ClinicalTrials.gov site itself rather than any change to the study record.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded Naples, Italy as a location and removed Napoli, Italy from the study locations.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Hepatocellular carcinoma keyword and Genetic and Rare Diseases Information Center resource. Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check45 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. The visible study details and layout remain unchanged.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded site revision label 'Revision: v3.4.2'; removed the prior operational notice and revision 'Revision: v3.4.1' related to government funding and operating status.SummaryDifference0.2%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.